Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2005 02:24 ET | Source: Galapagos Genomics

Galapagos Appoints David Smith as Chief Financial Officer

MECHELEN, Belgium, Nov. 9, 2005 (PRIMEZONE) -- Galapagos (Euronext:GLPG) (LSE:GLPG), a genomics-based drug discovery company, has appointed David R. Smith as Chief Financial Officer to Galapagos per...
November 02, 2005 04:06 ET | Source: Galapagos Genomics

Galapagos to Release Third Quarter Results on 10 November 2005

MECHELEN, Belgium, Nov. 2, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company (Euronext Brussels, GLPG; Euronext Amsterdam, GLPGA, London AiM: GLPG) announced today that it...
October 18, 2005 02:09 ET | Source: Galapagos Genomics

Galapagos Expands Its Collaboration With Serono

MECHELEN, Belgium, Oct. 18, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam: GLPGA) announced today that its services division BioFocus has reached agreement with the...
October 14, 2005 02:07 ET | Source: Galapagos Genomics

Galapagos Featured in Leading Drug Discovery Journal

MECHELEN, Belgium, Oct. 14, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces that an article presenting the Company's approach to target discovery will appear in...
October 13, 2005 05:30 ET | Source: Galapagos Genomics

Galapagos Declares the Offer for BioFocus Unconditional as to Acceptances

MECHELEN, Belgium, Oct. 13, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam - GLPGA) announces that on October 12, valid acceptances had been received for 12,552,464...
October 03, 2005 11:40 ET | Source: Galapagos Genomics

Galapagos to Webcast Analyst Day on Friday, October 7, 2005

MECHELEN, Belgium and LEIDEN, Netherlands Oct. 3, 2005 (PRIMEZONE) -- Galapagos NV (Euronext Amsterdam: GLPGA, Euronext Brussels: GLPG), invites investors, the media and the general public to view a...
September 21, 2005 02:00 ET | Source: Lakefront Biotherapeutics

Recommended Offer by Galapagos NV for BioFocus plc

Summary of the Offer A recommended all share offer by ING Corporate Finance, made on behalf of Galapagos, for the entire issued and to be issued ordinary share capital of BioFocus Galapagos to...
August 12, 2005 02:24 ET | Source: Galapagos Genomics

Galapagos Announces Half Year 2005 Results

Mechelen, Belgium, Aug. 12, 2005 (PRIMEZONE) -- Galapagos: - Financials on target for 2005 increased annual revenues and cash burn of around 7 million euro - Initial public offering...
August 10, 2005 02:12 ET | Source: Galapagos Genomics

Galapagos NV, ZoBio BV, Pyxis Discovery BV and Leiden University Collaborate in Arthritis Drug Discovery Program

MECHELEN, Belgium, Aug. 10, 2005 (PRIMEZONE) -- Galapagos NV, ZoBio BV, Pyxis Discovery BV and Leiden University announced today the formation of a four-way collaboration to pursue a small molecule...
August 10, 2005 02:00 ET | Source: Lakefront Biotherapeutics

Galapagos NV, ZoBio BV, Pyxis Discovery BV and Leiden University collaborate in arthritis drug discovery program

As a member of the collaborative effort, Galapagos will contribute its arthritis disease biology and a validated target for drug development, which has been discovered using its siRNA-based...